NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,930 Cr | ₹2,180 Cr | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr |
What is the latest Total Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹2,930 Cr |
| Mar2025 | ₹2,180 Cr |
| Mar2024 | ₹1,833 Cr |
| Mar2023 | ₹1,580 Cr |
| Mar2022 | ₹1,383 Cr |
How is Total Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,930 Cr | 34.42 | |
| Mar2025 | ₹2,180 Cr | 18.95 | |
| Mar2024 | ₹1,833 Cr | 16.00 | |
| Mar2023 | ₹1,580 Cr | 14.19 | |
| Mar2022 | ₹1,383 Cr | - | |
Compare Total Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹29,355.8 Cr | -0.1% | 20.3% | 71.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -0.1% |
20.3% |
71.5% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses